Follow up of asthmatic children: Definition and measurement tools;Suivi de l'enfant asthmatique: Définition et outils de mesure

Revue des Maladies Respiratoires

Volumn 25, Issue 6, 2008, Pages 695-704

  De Blic, J ^a   Deschildre, A ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Asthma; Child; Control; Exhaled nitric oxide; Questionnaires

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; NEDOCROMIL; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OMALIZUMAB; ANTIASTHMATIC AGENT;

ASTHMA; CONSULTATION; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE SEVERITY; EXERCISE; FOLLOW UP; HUMAN; LUNG FUNCTION TEST; QUESTIONNAIRE; RESPIRATORY TRACT INFLAMMATION; REVIEW; ADOLESCENT; AGE; ARTIFICIAL VENTILATION; BREATH ANALYSIS; CHILD; COMPARATIVE STUDY; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; TIME;

ADOLESCENT; ADRENAL CORTEX HORMONES; AGE FACTORS; ANTI-ASTHMATIC AGENTS; ASTHMA; BREATH TESTS; CHILD; CHILD, PRESCHOOL; FOLLOW-UP STUDIES; HUMANS; NITRIC OXIDE; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY FUNCTION TESTS; RESPIRATORY THERAPY; TIME FACTORS;

EID: 55249107342     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0761-8425(08)73799-9     Document Type: Review

References (69)

1. Warner JO, Naspitz CK : Third International Pediatric Consensus statement on the management of childhood asthma. International Pediatric Asthma Consensus Group. Pediatr Pulmonol 1998 ; 25 : 1-17.
2. www.ginasthma.com
3. National Asthma Education and Prevention Program : Expert panel report : guidelines for the diagnosis and management of asthma update on selected topics. J Allergy Clin Immunol 2002 ; 110 : S141-219.
4. Groupe de recherche sur les avancées en pneumopédiatrie : Du bon usage des corticoïdes inhalés chez l'enfant asthmatique (nourrisson inclus). Rev Mal Respir 2004 ; 21.
5. Cabral AL, Conceicao GM, Fonseca-Guedes CH, Martins MA : Exercise-induced bronchospasm in children : effects of asthma severity. Am J Respir Crit Care Med 1999 ; 159 : 1819-23.
6. Galant SP, Morphew T, Amaro S, Liao O : Current asthma guidelines may not identify young children who have experienced significant morbidity. Pediatrics 2006 ; 117 : 1038-45.
7. Bacharier LB, Strunk RC, Mauger D, White D, Lemanske RF, Jr., Sorkness CA : Classifying asthma severity in children : mismatch between symptoms, medication use, and lung function. Am J Respir Crit Care Med 2004 ; 170 : 426-32.
8. Spahn JD, Cherniack R, Paull K, Gelfand EW : Is forced expiratory volume in one second the best measure of severity in childhood asthma ? Am J Respir Crit Care Med 2004 ; 169 : 784-6.
9. Stout JW, Visness CM, Enright P, Lamm C, Shapiro G, Gan VN, Adams GK, 3rd, Mitchell HE : Classification of asthma severity in children : the contribution of pulmonary function testing. Arch Pediatr Adolesc Med 2006 ; 160 : 844-50.
10. Paull K, Covar R, Jain N, Gelfand EW, Spahn JD : Do NHLBI lung function criteria apply to children ? A cross-sectional evaluation of childhood asthma at National Jewish Medical and Research Center, 1999-2002. Pediatr Pulmonol 2005 ; 39 : 311-7.
11. Baatenburg de Jong A, Brouwer AF, Roorda RJ, Brand PL : Normal lung function in children with mild to moderate persistent asthma well controlled by inhaled corticosteroids. J Allergy Clin Immunol 2006 ; 118 : 280-2.
12. Miller MK, Johnson C, Miller DP, Deniz Y, Bleecker ER, Wenzel SE : Severity assessment in asthma : An evolving concept. J Allergy Clin Immunol 2005 ; 116 : 990-5.
13. Chipps BE, Spahn JD, Sorkness CA, Baitinger L, Sutton LB, Emmett AH, Dorinsky PM : Variability in asthma severity in pediatric subjects with asthma previously receiving short-acting beta2-agonists. J Pediatr 2006 ; 148 : 517-21.
14. Fuhlbrigge AL, Guilbert T, Spahn J, Peden D, Davis K : The influence of variation in type and pattern of symptoms on assessment in pediatric asthma. Pediatrics 2006 ; 118 : 619-25.
15. Blanc FX, Postel-Vinay N, Boucot I, de Blic J, Scheinmann P : Étude AIRE : analyse des données recueillies chez 753 enfants asthmatiques en Europe. Rev Mal Respir 2002 ; 19 : 585-92.
16. de Blic J, Boucot I, Pribil C, Huas D, Godard P : Niveau de contrôle de l'asthme chez l'enfant en médecine géné rale en France : résultats de l'étude ER'ASTHME. Arch Pediatr 2007 ; 14 : 1069-75.
17. Reznik M, Sharif I, Ozuah PO : Classifying asthma severity : prospective symptom diary or retrospective symptom recall ? J Adolesc Health 2005 ; 36 : 537-8.
18. de Blic J, Boucot I, Pribil C, Marguet C, Robert J, Huas D, Allaert FA : Niveau de contrôle de l'asthme chez l'enfant en France : étude ELIOS. 11e Congrès de Pneumologie de Langue Française ; Lyon, France. Rev Mal Respir 2007 ; 24 : 1S36-1S36. Abs 79.
19. ANAES : Recommandations pour le suivi médical des patients asthmatiques adultes et adolescents. Rev Mal Respir 2004 ; 21 : 1-10.
20. Boulet LP, Becker A, Bérubé D, Beveridge R, Ernst P : Canadian consensus report. Can Med Assoc J 1999 ; 161 (suppl 11).
21. Konig P, Shaffer J : The effect of drug therapy on long-term outcome of childhood asthma : a possible preview of the international guidelines. J Allergy Clin Immunol 1996 ; 98 : 1103-11.
22. Bahceciler NN, Barlan IB, Nuhoglu Y, Basaran MM : Risk factors for the persistence of respiratory symptoms in childhood asthma. Ann Allergy Asthma Immunol 2001 ; 86 : 449-55.
23. Timonen KL, Schwartz J, Nielsen J, Brunekreef B : Associations between markers of respiratory morbidity in European children. Eur Respir J 2002 ; 19 : 479-86.
24. Nair SJ, Daigle KL, DeCuir P, Lapin CD, Schramm CM : The influence of pulmonary function testing on the management of asthma in children. J Pediatr 2005 ; 147 : 797-801.
25. Juniper EF, O'Byrne PM, Ferrie PJ, King DR, Roberts JN : Measuring asthma control. Clinic questionnaire or daily diary ? Am J Respir Crit Care Med 2000 ; 162 : 1330-4.
26. van den Nieuwenhof L, Schermer T, Eysink P, Halet E, van Weel C, Bindels P, Bottema B : Can the Asthma Control Questionnaire be used to differentiate between patients with controlled and uncontrolled asthma symptoms ? A pilot study. Fam Pract 2006 ; 23 : 674-81.
27. Schatz M, Sorkness CA, Li JT, Marcus P, Murray JJ, Nathan RA, Kosinski M, Pendergraft TB, Jhingran P : Asthma Control Test : reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol 2006 ; 117 : 549-56.
28. Skinner EA, Diette GB, Algatt-Bergstrom PJ, Nguyen TT, Clark RD, Markson LE, Wu AW : The Asthma Therapy Assessment Questionnaire (ATAQ) for children and adolescents. Dis Manag 2004 ; 7 : 305-13.
29. Liu AH, Zeiger R, Sorkness C, Mahr T, Ostrom N, Burgess S, Rosenzweig JC, Manjunath R : Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol 2007 ; 119 : 817-25.
30. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB : Development of the asthma control test : a survey for assessing asthma control. J Allergy Clin Immunol 2004 ; 113 : 59-65.
31. Roussel H : Traitement anti-asthmatique et suivi des patients en 2002 : apport des données du régime général. Médistat 2004 ; 10 : 6-8.
32. Fuhlbrigge AL, Kitch BT, Paltiel AD, Kuntz KM, Neumann PJ, Dockery DW, Weiss ST : FEV(1) is associated with risk of asthma attacks in a pediatric population. J Allergy Clin Immunol 2001 ; 107 : 61-7.
33. Fuhlbrigge AL, Weiss ST, Kuntz KM, Paltiel AD : Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma. Pediatrics 2006 ; 118 : e347-55.
34. Tantisira KG, Fuhlbrigge AL, Tonascia J, Van Natta M, Zeiger RS, Strunk RC, Szefler SJ, Weiss ST : Bronchodilation and bronchoconstriction : predictors of future lung function in childhood asthma. J Allergy Clin Immunol 2006 ; 117 : 1264-71.
35. Sont JK, Willems LN, Bel EH, van Krieken JH, Vandenbroucke JP, Sterk PJ : Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 1999 ; 159 : 1043-51.
36. Green RH, Brightling CE, McKenna S, Hargadon B, Neale N, Parker D, Ruse C, Hall IP, Pavord ID : Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness. Eur Respir J 2006 ; 27 : 1144-51.
37. Groupe de recherche sur les avancées en pneumopédiatrie : Place des EFR dans l'évaluation et la surveillance de l'asthme chez l'enfant de plus de 3 ans. Rev Mal Respir 2003 ; 20 : 638-43.
38. Wensley D, Silverman M : Peak flow monitoring for guided self-management in childhood asthma : a randomized controlled trial. Am J Respir Crit Care Med 2004 ; 170 : 606-12.
39. Kamps AW, Roorda RJ, Brand PL : Peak flow diaries in childhood asthma are unreliable. Thorax 2001 ; 56 : 180-2.
40. Meuric S, Leroy M, Raffestin B, Bidat E : Observance et acceptabilité d'un nouveau débitmètre de pointe électronique, le PiKo-1. Rev Mal Respir 2005 ; 22 : 935-41.
41. Götz M : Asthme de deux à cinq ans : une période clé. Rev Fr Allergol Immunol Clin 2006 ; 46 : 560-5.
42. Taylor DR, Pijnenburg MW, Smith AD, De Jongste JC : Exhaled nitric oxide measurements : clinical application and interpretation. Thorax 2006 ; 61 : 817-27.
43. Warke TJ, Fitch PS, Brown V, Taylor R, Lyons JD, Ennis M, Shields MD : Exhaled nitric oxide correlates with airway eosinophils in childhood asthma. Thorax 2002 ; 57 : 383-7.
44. Payne DN, Adcock IM, Wilson NM, Oates T, Scallan M, Bush A : Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med 2001 ; 164 : 1376-81.
45. de Blic J, Tillie-Leblond I, Emond S, Mahut B, Dang Duy TL, Scheinmann P : High-resolution computed tomography scan and airway remodeling in children with severe asthma. J Allergy Clin Immunol 2005 ; 116 : 750-4.
46. Visser MJ, Postma DS, Arends LR, de Vries TW, Duiverman EJ, Brand PL : One-year treatment with different dosing schedules of fluticasone propionate in childhood asthma. Effects on hyperresponsiveness, lung function, and height. Am J Respir Crit Care Med 2001 ; 164 : 2073-7.
47. Beck-Ripp J, Griese M, Arenz S, Koring C, Pasqualoni B, Bufler P : Changes of exhaled nitric oxide during steroid treatment of childhood asthma. Eur Respir J 2002 ; 19 : 1015-9.
48. Lonnkvist K, Anderson M, Hedlin G, Svartengren M : Exhaled NO and eosinophil markers in blood, nasal lavage and sputum in children with asthma after withdrawal of budesonide. Pediatr Allergy Immunol 2004 ; 15 : 351-8.
49. Fritsch M, Uxa S, Horak F, Jr., Putschoegl B, Dehlink E, Szepfalusi Z, Frischer T : Exhaled nitric oxide in the management of childhood asthma : a prospective 6-months study. Pediatr Pulmonol 2006 ; 41 : 855-62.
50. Pijnenburg MW, Bakker EM, Hop WC, De Jongste JC : Titrating steroids on exhaled nitric oxide in children with asthma : a randomized controlled trial. Am J Respir Crit Care Med 2005 ; 172 : 831-6.
51. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR : Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005 ; 352 : 2163-73.
52. Petersen R, Agertoft L, Pedersen S : Treatment of exercise-induced asthma with beclomethasone dipropionate in children with asthma. Eur Respir J 2004 ; 24 : 932-7.
53. Buchvald F, Eiberg H, Bisgaard H : Heterogeneity of FeNO response to inhaled steroid in asthmatic children. Clin Exp Allergy 2003 ; 33 : 1735-40.
54. Piacentini GL, Bodini A, Costella S, Vicentini L, Mazzi P, Suzuki Y, Peroni D, Boner AL : Exhaled nitric oxide in asthmatic children exposed to relevant allergens : effect of flunisolide. Eur Respir J 2000 ; 15 : 730-4.
55. Raissy HH, Wright H, Crowley M, Marshik P, Colon-Semidy A, Kelly HW : Comparison of the Systemic Effects of Fluticasone Propionate and Triamcinolone Acetonide Administered in Equipotent Doses in Children with Asthma. Pediatric Asthma, Allergy & Immunology 2003 ; 16 : 283-93.
56. Ghiro L, Zanconato S, Rampon O, Piovan V, Pasquale MF, Baraldi E : Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children. Eur Respir J 2002 ; 20 : 630-4.
57. Zeiger RS, Szefler SJ, Phillips BR, Schatz M, Martinez FD, Chinchilli VM, Lemanske RF, Jr., Strunk RC, Larsen G, Spahn JD, Bacharier LB, Bloomberg GR, Guilbert TW, Heldt G, Morgan WJ, Moss MH, Sorkness CA, Taussig LM : Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma. J Allergy Clin Immunol 2006 ; 117 : 45-52.
58. Szefler SJ, Phillips BR, Martinez FD, Chinchilli VM, Lemanske RF, Strunk RC, Zeiger RS, Larsen G, Spahn JD, Bacharier LB, Bloomberg GR, Guilbert TW, Heldt G, Morgan WJ, Moss MH, Sorkness CA, Taussig LM : Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol 2005 ; 115 : 233-42.
59. Pedroletti C, Lundahl J, Alving K, Hedlin G : Exhaled nitric oxide in asthmatic children and adolescents after nasal allergen challenge. Pediatr Allergy Immunol 2005 ; 16 : 59-64.
60. Caffey LF, Raissy HH, Marshik P, Kelly HW : A Crossover Comparison of Fluticasone Propionate and Montelukast on Inflammatory Indices in Children with Asthma. Pediatric Asthma, Allergy & Immunology 2005 ; 18 : 123-30.
61. Piacentini GL, Peroni DG, Del Giudice MM, Bodini A, Costella S, Vicentini L, Boner AL : Effect of montelukast on exhaled NO in asthmatic children exposed to relevant allergens. Pediatr Allergy Immunol 2002 ; 13 : 137-9.
62. Carra S, Gagliardi L, Zanconato S, Scollo M, Azzolin N, Zacchello F, Baraldi E : Budesonide but not nedocromil sodium reduces exhaled nitric oxide levels in asthmatic children. Respir Med 2001 ; 95 : 734-9.
63. Whelan GJ, Blake K, Kissoon N, Duckworth LJ, Wang J, Sylvester JE, Lima JJ : Effect of montelukast on time-course of exhaled nitric oxide in asthma : influence of LTC4 synthase A(-444)C polymorphism. Pediatr Pulmonol 2003 ; 36 : 413-20.
64. Bratton DL, Lanz MJ, Miyazawa N, White CW, Silkoff PE : Exhaled nitric oxide before and after montelukast sodium therapy in school-age children with chronic asthma : a preliminary study. Pediatr Pulmonol 1999 ; 28 : 402-7.
65. Bisgaard H, Loland L, Oj JA : NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast. Am J Respir Crit Care Med 1999 ; 160 : 1227-31.
66. Fuglsang G, Vikre-Jorgensen J, Agertoft L, Pedersen S : Effect of salmeterol treatment on nitric oxide level in exhaled air and dose-response to terbutaline in children with mild asthma. Pediatr Pulmonol 1998 ; 25 : 314-21.
67. Buchvald F, Bisgaard H : Comparisons of the complementary effect on exhaled nitric oxide of salmeterol vs montelukast in asthmatic children taking regular inhaled budesonide. Ann Allergy Asthma Immunol 2003 ; 91 : 309-13.
68. Silkoff PE, Romero FA, Gupta N, Townley RG, Milgrom H : Exhaled nitric oxide in children with asthma receiving Xolair (omalizumab), a monoclonal anti-immunoglobulin E antibody. Pediatrics 2004 ; 113 : e308-12.
69. Tsai YG, Lee MY, Yang KD, Chu DM, Yuh YS, Hung CH : A single dose of nebulized budesonide decreases exhaled nitric oxide in children with acute asthma. J Pediatr 2001 ; 139 : 433-7